Mendelman P M, Chaffin D O, Clausen C, Stull T L, Needham C, Williams J D, Smith A L
Antimicrob Agents Chemother. 1986 Aug;30(2):274-80. doi: 10.1128/AAC.30.2.274.
We questioned whether the apparent rarity of ampicillin-resistant, non-beta-lactamase-producing (NBLP) Haemophilus influenzae was due to failure of detection. We identified ampicillin-resistant and ampicillin-susceptible H. influenzae by the agar dilution technique, using 10(5)- and 10(3)-CFU inocula. We compared the disk susceptibility of 18 ampicillin-resistant NBLP strains, 13 ampicillin-resistant, beta-lactamase-producing strains, and 10 ampicillin-susceptible strains by using standard 10- and 2-micrograms ampicillin disks on two different media. We also investigated the possibility that disks containing 10 micrograms of clavulanic acid and 2 micrograms of ampicillin could be used to distinguish between the two ampicillin-resistant populations. Using the disk containing 2 micrograms of ampicillin, we correctly differentiated all the ampicillin-resistant isolates from the ampicillin-susceptible isolates on both media (a zone diameter of less than or equal to 15 mm was considered resistant). In contrast, the 10-micrograms ampicillin disk failed to detect 44% (8 of 18) of the ampicillin-resistant NBLP strains (a zone diameter of less than or equal to 19 mm was considered resistant). The MIC of ampicillin with the 10(3)-CFU inoculum correlated better with zone diameters than with the 10(5)-CFU inoculum. A difference in zone diameters of greater than or equal to 8 mm between the disk containing 10 micrograms of clavulanic acid and 2 micrograms of ampicillin and the disk containing only 2 micrograms of ampicillin correctly identified all beta-lactamase-producing strains. We conclude that the 2-micrograms ampicillin disk tests more readily identify ampicillin resistance in H. influenzae than do the 10-micrograms ampicillin disk tests. Future investigation should determine whether this in vitro resistance correlates with clinical treatment failures.
我们质疑耐氨苄西林、非β-内酰胺酶产生菌(NBLP)的流感嗜血杆菌明显罕见是否是由于检测失败所致。我们采用琼脂稀释技术,分别接种10⁵和10³CFU,鉴定出耐氨苄西林和对氨苄西林敏感的流感嗜血杆菌。我们在两种不同培养基上,使用标准的10微克和2微克氨苄西林纸片,比较了18株耐氨苄西林NBLP菌株、13株耐氨苄西林、产β-内酰胺酶菌株和10株对氨苄西林敏感菌株的纸片药敏情况。我们还研究了含10微克克拉维酸和2微克氨苄西林的纸片能否用于区分这两种耐氨苄西林菌群体的可能性。使用含2微克氨苄西林的纸片,我们在两种培养基上均能正确区分所有耐氨苄西林分离株和对氨苄西林敏感的分离株(抑菌圈直径小于或等于15毫米被视为耐药)。相比之下,10微克氨苄西林纸片未能检测出44%(18株中的8株)耐氨苄西林NBLP菌株(抑菌圈直径小于或等于19毫米被视为耐药)。接种10³CFU时氨苄西林的最低抑菌浓度(MIC)与抑菌圈直径的相关性优于接种10⁵CFU时。含10微克克拉维酸和2微克氨苄西林的纸片与仅含2微克氨苄西林的纸片之间抑菌圈直径相差大于或等于8毫米,可正确鉴定所有产β-内酰胺酶菌株。我们得出结论,与10微克氨苄西林纸片检测相比,2微克氨苄西林纸片检测能更轻松地鉴定流感嗜血杆菌对氨苄西林的耐药性。未来的研究应确定这种体外耐药性是否与临床治疗失败相关。